Prime Medicine, Inc. (PRME) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts PRME Hot Sheet
Join SI Premium – FREE
Prime Medicine, Inc. (NASDAQ: PRME) reported Q3 EPS of ($0.55), $0.14 worse than the analyst estimate of ($0.41).
For earnings history and earnings-related data on Prime Medicine, Inc. (PRME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nayax Ltd. (NYAX) Misses Q2 EPS by 39c; reaffirms guidance
- AG Mortgage Investment Trust (MITT) Misses Q2 EPS by 3c
- Strive Asset Management, LLC (ASST) Reports Q2 Loss of $3.65
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
